D-Dimer Serum Level Association With Mortality In Acute Stroke Patiens With Covid-19
DOI:
https://doi.org/10.22219/sm.Vol20.SMUMM2.33479Abstract
Background: Since WHO declared COVID-19 a pandemic, Indonesia, including RSUD Gambiran Kediri, has experienced a sharp increase in morbidity and mortality. The global incidence of acute stroke in COVID-19 patients is 1.4%, with symptoms varying from mild to severe, including death. Elevated serum D-dimer in COVID-19 patients can be a biomarker to predict severe complications.
Objective: This study aims to determine the relationship between elevated serum D-dimer levels (mild, moderate, severe) with mortality in acute stroke patients with COVID-19.
Methods: Observational analytic study with a cross-sectional method using secondary data from medical records of patients admitted to RSUD Gambiran Kediri from March 2020 to June 2023. Patients were categorized based on serum D-dimer levels: normal (<0.5 mg/L), mild (<1 mg/L), moderate (1-2 mg/L), and severe (>2 mg/L).
Results: Of 101 acute stroke patients with COVID-19, 52.48% were male. A total of 90 patients had elevated D-dimer levels, with 44 patients dying. Spearman correlation test and Chi-square test showed no significant association between D-dimer levels and mortality (p>0.005).
Conclusion: There is no association between elevated serum D-dimer levels and mortality in acute stroke patients with COVID-19.
Downloads
References
Aditianingsih, D. et al. (2023) ‘Dose response relationship between D-dimer level and mortality in critically ill COVID-19 patients: a retrospective observational study’, F1000Research, 11. Available at: https://doi.org/10.12688/f1000research.108972.2.
Akbar, N.A. et al. (2022) ‘Analysis of the Relationship between Laboratory Biomarkers and the Severity of COVID-19 at Kaliwates General Hospital Jember’, Journal of Agromedicine and Medical Sciences, 8(1), p. 51. Available at: https://doi.org/10.19184/ams.v8i1.29062.
Anggraini, R. et al. (2023) ‘D-dimer level differences in pneumonia patients than in COVID-19’, Bali Medical Journal, 12(3), pp. 2828–2831. Available at: https://doi.org/10.15562/bmj.v12i3.4359.
Atmaja, K.S. et al. (2021) ‘Hubungan konsentrasi serum C-Reactive Protein dan D-dimer dengan derajat keparahan dan mortalitas pasien COVID-19’, Intisari Sains Medis, 12(2), pp. 680–685. Available at: https://doi.org/10.15562/ism.v12i2.971.
Bao, W. et al. (2017) ‘Correlation of D-dimer level with the inflammatory conditions: a retrospective study’, AME Medical Journal, 2, pp. 27–27. Available at: https://doi.org/10.21037/amj.2017.02.07.
Chekol, S.G.E. (2020) ‘Assessment of plasma D-dimer level and its correlation with disease severity among hypertensive patients’. Available at: https://doi.org/10.20372/JSID/2020-31.
Cheng, L. et al. (2022) ‘D-dimer as a predictor of cardiovascular outcomes in patients with diabetes mellitus’, BMC Cardiovascular Disorders, 22(1), p. 82. Available at: https://doi.org/10.1186/s12872-022-02531-x.
Eljamay, S.M., Younis, M.M. and Elgebaily, E.S.M. (2022) ‘The relationship of D-Dimer level with various diseases’, Data Sciences Indonesia (DSI), 2(2), pp. 50–59. Available at: https://doi.org/10.47709/dsi.v2i2.1922.
Faltehal, F.N. and Hapsah, H. (2023) ‘Hubungan nilai D-dimer terhadap mortalitas pada pasien COVID-19 derajat berat di RSUD Dr.pirngadi Medan tahun 2020-2021’, Detector: Jurnal Inovasi Riset Ilmu Kesehatan, 1(4), pp. 220–229. Available at: https://doi.org/10.55606/detector.v1i4.2609.
Gallo-Guerrero, M. et al. (2022) ‘Cerebrovascular disease and mortality in hospitalized patients with COVID-19 in a Latin American country, Peru.’, Revista De Neuro-Psiquiatria, 85(3). Available at: https://doi.org/10.20453/rnp.v85i3.4329.
Hayıroğlu, M.İ. et al. (2021) ‘Mean serum D-dimer level to predict in-hospital mortality in COVID-19’, Revista Da Associação Médica Brasileira, 67(3). Available at: https://doi.org/10.1590/1806-9282.20200896.
Khudhur, Z.O. et al. (2024) ‘Gender-based differences of d-dimer levels among mild COVID-19 patients living in the erbil city-iraq’, EURASIAN JOURNAL OF SCIENCE AND ENGINEERING [Preprint].
Kim, Y. et al. (2021) ‘Predicting In-hospital Mortality Using D-Dimer in COVID-19 Patients With Acute Ischemic Stroke’, Frontiers in Neurology, 12, p. 702927. Available at: https://doi.org/10.3389/fneur.2021.702927.
Kuriakose, D. and Xiao, Z. (2020) ‘Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives’, International Journal of Molecular Sciences, 21(20), p. 7609. Available at: https://doi.org/10.3390/ijms21207609.
Kurosawa, Y. et al. (2022) ‘The Prognostic Impact of D-Dimer on Long-Term Mortality in Patients with Coronary Artery Disease after Percutaneous Coronary Intervention’, International Heart Journal, 63(6), pp. 1070–1077. Available at: https://doi.org/10.1536/ihj.22-377.
Lin, Y. et al. (2022) ‘D-Dimer Is Associated With Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease and Preserved Ejection Fraction’, Frontiers in Cardiovascular Medicine, 9, p. 937952. Available at: https://doi.org/10.3389/fcvm.2022.937952.
Magoon, R., Jose, J. and Choudhary, N. (2022) ‘Fibrinolysis and D-dimer in COVID-19: A Twisted Plot!’, Indian Journal of Critical Care Medicine, 26(2), pp. 164–166. Available at: https://doi.org/10.5005/jp-journals-10071-24105.
Mukaz, D.K. et al. (2023) ‘D-dimer and the risk of hypertension: The REasons for Geographic And Racial Differences in Stroke Cohort Study’, Research and Practice in Thrombosis and Haemostasis, 7(1). Available at: https://doi.org/10.1016/j.rpth.2022.100016.
Mus, R. et al. (2021) ‘Studi Literatur: Tinjauan Pemeriksaan Laboratorium pada Pasien COVID-19’, Jurnal Kesehatan Vokasional, 5(4), p. 242. Available at: https://doi.org/10.22146/jkesvo.58741.
Nannoni, S. et al. (2021) ‘Stroke in COVID-19: A systematic review and meta-analysis’, International Journal of Stroke, 16(2), pp. 137–149. Available at: https://doi.org/10.1177/1747493020972922.
Okuyan, D.Y. (2021) ‘Comparison of patients with acute ischemic stroke with and without COVID-19’, Neurology Asia, 26(3). Available at: https://doi.org/10.54029/2021isz.
Patil, S., Khule, S. and Toshniwal, S. (2023) ‘Role of D-Dimer in assessing severity, monitoring, and predicating outcome in COVID-19 pneumonia: A single center study’, Global Journal of Health Sciences and Research, 1, pp. 31–37. Available at: https://doi.org/10.25259/GJHSR_11_2023.
Suhesty, C. et al. (2023) ‘Correlation between Neutrophile to Lymphocyte Ratio and D-dimer with COVID-19 Severity’, Jurnal Kesehatan, 14(2), pp. 382–387. Available at: https://doi.org/10.26630/jk.v14i2.3775.
Tarmidi, M.S.P. and Bahrudin, M. (2024) ‘The Relationship between Level of D-Dimer Serum with Mortality in Acute Stroke Patiens with COVID-19’, Magna Neurologica, 2(2), pp. 54–59. Available at: https://doi.org/10.20961/magnaneurologica.v2i2.955.
Thachil, J., Favaloro, E.J. and Lippi, G. (2022) ‘D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19’, Seminars in Thrombosis and Hemostasis, 48(06), pp. 672–679. Available at: https://doi.org/10.1055/s-0042-1748193.
Tigner, A., Ibrahim, S.A. and Murray, I.V. (2024) ‘Histology, White Blood Cell’, in StatPearls. Treasure Island (FL): StatPearls Publishing. Available at: http://www.ncbi.nlm.nih.gov/books/NBK563148/ (Accessed: 3 December 2024).
Toker, A.K. et al. (2022) ‘Quick COVID-19 Severity Index, CURB-65 and Quick SOFA Scores Comparison in Predicting Mortality and Risk Factors of COVID-19 Patients’, Archives of Iranian Medicine, 25(7). Available at: https://doi.org/10.34172/aim.2022.73.
Weitz, J.I., Fredenburgh, J.C. and Eikelboom, J.W. (2017) ‘A Test in Context: D-Dimer’, Journal of the American College of Cardiology, 70(19), pp. 2411–2420. Available at: https://doi.org/10.1016/j.jacc.2017.09.024.
WHO (2020) Coronavirus disease (covid-19). Available at: https://www.who.int/health-topics/coronavirus#tab=tab_1 (Accessed: 27 March 2022).
Widjaja, A., Bw, I. and Ks, I. (2019) ‘Uji diagnostik pemeriksaan kadar D-dimer plasma pada diagnosis stroke iskemik’, Jurnal UMJ, 3(2), pp. 22–34.
Xing, Y. et al. (2021) ‘D-dimer daily continuous tendency predicts the short-term prognosis for COVID-19 independently: A retrospective study from Northeast China’, Clinical Hemorheology and Microcirculation, 79(2). Available at: https://doi.org/10.3233/ch-201071.
Yao, Y. et al. (2020) ‘D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study’, Journal of Intensive Care, 8(1), p. 49. Available at: https://doi.org/10.1186/s40560-020-00466-z.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Syahrial, Akhdan, Nurul, Ory, Gibran, Sintia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
